Hoechst Marion Roussel medicine development

Hoechst Marion Roussel, a major player in the global pharmaceutical industry, is committed to building a world-class team of scientists dedicated to Drug Innovation & Approval. Our new state-of-the-art $70 million facility, has more than doubled the U.S. Research capabilities at our scenic campus in Bridgewater, New Jersey. These modern facilities with spacious labs and open interaction areas facilitate an exciting and creative team environment. All of our highly skilled scientists, participate on U.S. Drug Innovation teams, pursuing novel therapeutic targets for the treatment of Alzheimer's disease, asthma, cancer, schizophrenia, and stroke.